Hamartoma diagnostic study of choice

	Hamartoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamartoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamartoma diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamartoma diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamartoma diagnostic study of choice
CDC on Hamartoma diagnostic study of choice
Hamartoma diagnostic study of choice in the news
Blogs on Hamartoma diagnostic study of choice
Directions to Hospitals Treating Hamartoma
Risk calculators and risk factors for Hamartoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Shyam Patel [2]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [3]

Overview

The diagnostic study of choice of hamartomas is tissue biopsy.

The diagnostic study of choice of hamartomas is tissue biopsy. However, imaging such as CT or MRI can also help to assess for hamartoma.